...
首页> 外文期刊>Contraception >Effect of a combined estrogen and progesterone oral contraceptive on circulating adipocytokines adiponectin, resistin and DLK-1 in normal and obese female rhesus monkeys
【24h】

Effect of a combined estrogen and progesterone oral contraceptive on circulating adipocytokines adiponectin, resistin and DLK-1 in normal and obese female rhesus monkeys

机译:雌,孕激素联合口服避孕药对正常和肥胖雌性恒河猴循环脂联素,抵抗素和DLK-1的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background Hormonal contraception is the most common medication used by reproductive aged women but there is little understanding of the impact of hormonal contraception on obesity and metabolism. Adipokine levels (adiponectin, resistin) and markers of adipocyte development (DLK-1) are altered in obese animals and humans and are associated with increased cardiovascular risk. We sought to determine the effect of combined hormonal oral contraceptive pills (COCs) on circulating adiponectin, resistin and DLK-1 levels in obese and normal-weight rhesus macaque monkeys. Methods Serum adiponectin, resistin and DLK-1 levels in reproductive-age female rhesus macaques of normal (n = 5, mean = 5.76 kg) and inherently obese (n = 5, mean = 8.11 kg) weight were determined before, during and 2 months after cessation of 8 months of continuous treatment with COCs. Results The obese group alone showed a significant decrease (p<.01) in weight with COC use, which returned to baseline after COC cessation. Baseline adiponectin levels prior to COC treatment were lower in the obese group (p<.05). Adiponectin levels increased from baseline in both groups, but more so in the obese group (p<.05). Resistin levels were similar at baseline, with an increase in both groups following treatment. Circulating resistin remained elevated above baseline levels after COC cessation, particularly in the obese group (p<.05). While DLK-1 levels did not change significantly in either group, a trend for higher levels in obese animals was observed. Conclusions COC use may alter metabolic processes via direct (resistin) or indirect (adiponectin) means, while unchanging DLK1 levels suggest they do not affect adipocyte development. COCs may directly increase resistin levels, as observed in both groups. As adiponectin is inversely related to adipocyte mass, increased levels in the obese group are likely attributed to weight loss.
机译:背景技术激素避孕是老年育龄妇女最常用的药物,但对激素避孕对肥胖和代谢的影响知之甚少。肥胖动物和人类中的脂肪因子水平(脂联素,抵抗素)和脂肪细胞发育的标志物(DLK-1)发生改变,并与心血管风险增加有关。我们试图确定激素口服避孕药(COCs)对肥胖和正常体重恒河猴猕猴循环脂联素,抵抗素和DLK-1水平的影响。方法在正常体重(n = 5,平均体重= 5.76 kg)和固有肥胖(n = 5,平均= 8.11 kg)体重的生殖年龄雌性猕猴中,在之前,期间和2时测定血清脂联素,抵抗素和DLK-1水平停止使用COC连续治疗8个月后的3个月。结果单独的肥胖组在使用COC的情况下体重显着降低(p <.01),在停止COC后恢复到基线。肥胖组中,COC治疗前的基线脂联素水平较低(p <.05)。两组脂联素水平均较基线水平升高,而肥胖组则更高(p <.05)。抵抗素水平在基线时相似,两组在治疗后均增加。停止COC后,循环抵抗素仍高于基线水平,特别是在肥胖组中(p <.05)。尽管两组中的DLK-1水平均无显着变化,但观察到肥胖动物中DLK-1水平有升高的趋势。结论使用COC可能通过直接(抵抗素)或间接(脂联素)手段改变代谢过程,而DLK1水平不变则表明它们不影响脂肪细胞的发育。两组都观察到,COC可能会直接增加抵抗素水平。由于脂联素与脂肪细胞质量成反比,因此肥胖组水平的升高可能归因于体重减轻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号